Browse Conditions Browse Medicines

NICE guidance on the management of ulcerative colitis

For Ulcerative colitis

The National Institute for Health and Care Excellence (NICE) have updated their guidance on the management of ulcerative colitis.

This guideline covers the management of ulcerative colitis in children, young people and adults. It aims to help professionals to provide consistent high-quality care and it highlights the importance of advice and support for people with ulcerative colitis.

Ulcerative colitis is a lifelong condition in which the large bowel (colon) becomes inflamed. It can cause abdominal pain, diarrhoea (which may be bloody), tiredness and weight loss. Symptoms usually come and go, suddenly flaring up before easing off for a few weeks or months. Because flare-ups are unpredictable, living with ulcerative colitis can cause anxiety and stress. There is no cure, so the aim of treatment is to control symptoms as much as possible and help people have the best quality of life they can.

NICE want this guideline to make a difference to people with ulcerative colitis by making sure:
  • doctors know the best way to treat flare-ups, depending how severe they are and how much of your bowel is affected
  • your doctor fully explains the pros and cons of different drug treatments to prevent flare-ups, so you can choose what’s right for you
  • you get specialist advice on what to expect if surgery is a possible treatment option for you

You can follow developments in ulcerative colitis by using our Condition Tracker service which provides users with updates about the conditions and medicines they are interested in.

About ulcerative colitis (source NHS)
Ulcerative colitis is a long-term condition where the colon and rectum become inflamed.

The colon is the large intestine (bowel), and the rectum is the end of the bowel where stools are stored.

Small ulcers can develop on the colon's lining, and can bleed and produce pus.

NHS website for ulcerative colitis
Contains public sector information licensed under the Open Government Licence v3.0.
Accessed 13/05/19
Links available in full article

© NICE [2019]

Ulcerative colitis: management. NICE guideline [NG130] Published date: May 2019
Available from: See Link below. All rights reserved. Subject to Notice of rights
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

The information provided by NICE was accurate at the time this article was issued.

NICE guidance update: Ulcerative colitis: management

Reporting of suspected adverse reactions

Reporting suspected adverse reactions (side effects) after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals or patients are asked to report any suspected adverse reactions via the Yellow Card Scheme at or search for MHRA Yellow Card in the Google Play or Apple App Store.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. We cannot provide individual medical advice. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.

About condition